Advertisement
Canada markets open in 6 hours 27 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7309
    +0.0011 (+0.15%)
     

  • CRUDE OIL

    82.98
    +0.17 (+0.21%)
     

  • Bitcoin CAD

    87,935.29
    -3,434.87 (-3.76%)
     

  • CMC Crypto 200

    1,389.65
    +7.08 (+0.51%)
     

  • GOLD FUTURES

    2,333.30
    -5.10 (-0.22%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,450.00
    -214.50 (-1.21%)
     

  • VOLATILITY

    15.97
    0.00 (0.00%)
     

  • FTSE

    8,040.38
    0.00 (0.00%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Actelion shares fall on report it rejects J&J offer

Reuters
A general view shows Swiss biotech group Actelion Headquarters in Allschwil near Basel February 17, 2015. REUTERS/Arnd Wiegmann (Reuters)

ZURICH (Reuters) - Shares in Swiss biotech company Actelion fell more than 6 percent after news outlet streetinsider.com reported on Wednesday the company had rejected a full takeover offer by U.S. healthcare group Johnson & Johnson and may sell a unit. Actelion declined to comment on the report, which cited an unidentified source, and referred to a statement the company had published on Friday. The companies had confirmed last week they were in talks about a possible transaction. (Reporting by Paul Arnold, Editing by Michael Shields)